Chemoinformaics analysis of 3-Methylvaleric acid
| Molecular Weight | 116.16 | nRot | 3 |
| Heavy Atom Molecular Weight | 104.064 | nRig | 1 |
| Exact Molecular Weight | 116.084 | nRing | 0 |
| Solubility: LogS | -1.052 | nHRing | 0 |
| Solubility: LogP | 1.754 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 8 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 19.6255 |
| nHD | 1 | BPOL | 12.9065 |
| QED | 0.606 |
| Synth | 2.396 |
| Natural Product Likeliness | 1.026 |
| NR-PPAR-gamma | 0.122 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.001 |
| HIA | 0.006 |
| CACO-2 | -4.584 |
| MDCK | 0.0000697 |
| BBB | 0.919 |
| PPB | 0.454158 |
| VDSS | 0.248 |
| FU | 0.520623 |
| CYP1A2-inh | 0.03 |
| CYP1A2-sub | 0.263 |
| CYP2c19-inh | 0.02 |
| CYP2c19-sub | 0.653 |
| CYP2c9-inh | 0.011 |
| CYP2c9-sub | 0.946 |
| CYP2d6-inh | 0.007 |
| CYP2d6-sub | 0.167 |
| CYP3a4-inh | 0.007 |
| CYP3a4-sub | 0.082 |
| CL | 9.222 |
| T12 | 0.794 |
| hERG | 0.006 |
| Ames | 0.007 |
| ROA | 0.133 |
| SkinSen | 0.223 |
| Carcinogencity | 0.238 |
| EI | 0.993 |
| Respiratory | 0.186 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.950833 |